Multiple roles for the major histocompatibility complex class I-related receptor FcRn

Annual Review of Immunology

Volumn 18, Issue , 2000, Pages 739-766

  Ghetie, Victor ^a   Ward, E Sally ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Gammaglobulin; Maternofetal intestinal transfer of IgGs; Neonatal Fc receptor; Serum half life; Transcytosis

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

BINDING SITE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR INTERACTION; NEWBORN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOGLOBULIN G; RECEPTORS, FC;

EID: 0034042660     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.18.1.739     Document Type: Review

References (144)

1. Jones EA, Waldmann TA. 1972. The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat. J. Clin. Invest. 51:2916-27
2. Rodewald R. 1973. Intestinal transport of antibodies in the newborn rat. J. Cell Biol. 58:189-211
3. Rodewald R. 1976. pH-dependent binding of immunoglobulins to intestinal cells of the neonatal rat. J. Cell Biol. 71:666-69
4. Rodewald R. 1980. Distribution of immunoglobulin G receptors in the small intestine of the young rat. J. Cell Biol. 85:18-32
5. Rodewald R, Abrahamson DR. 1982. Receptor-mediated transport of IgG across the intestinal epithelium of the neonatal rat. Ciba Found. Symp. 94:209-32
6. Wallace KH, Rees AR. 1980. Studies on the immunoglobulin-G Fc-fragment receptor from neonatal rat small intestine. Biochem. J. 188:9-16
7. Roberts DM, Guenthert M, Rodewald R. 1990. Isolation and characterization of the Fc receptor from the fetal yolk sac of the rat. J. Cell Biol. 111:1867-76
8. Zijlstra M, Bix M, Simister NE, Loring JM, Raulet DH, Jaenisch R. 1990. Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 344:742-46
9. Medesan C, Radu C, Kim JK, Ghetie V, Ward ES. 1996. Localization of the site of the IgG molecule that regulates maternofetal transmission in mice. Eur. J. Immunol. 26:2533-36
10. Ghetie V, Hubbard JG, Kim JK, Tsen MF, Lee Y, Ward ES. 1996. Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice. Eur. J. Immunol. 26:690-96
11. Junghans RP, Anderson CL. 1996. The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor. Proc. Natl. Acad. Sci. USA 93:5512-16
12. Israel EJ, Wilsker DF, Hayes KC, Schoenfeld D, Simister NE. 1996. Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn. Immunology 89:573-78
13. Christianson GJ, Brooks W, Vekasi S, Manolfi EA, Niles J, Roopenian SL, Roths JB, Rothlein R, Roopenian DC. 1997. Beta 2-microglobulin-deficient mice are protected from hypergammaglobulinemia and have defective antibody responses because of increased IgG catabolism. J. Immunol. 159:4781-92
14. Ghetie V, Ward ES. 1997. FcRn: the MHC class I-related receptor that is more than an IgG transporter. Immunol. Today 18:592-98
15. Ellinger I, Schwab M, Stefanescu A, Hunziker W, Fuchs R. 1999. IgG transport across trophoblast-derived BeWo cells: a model system to study IgG transport in the placenta. Eur. J. Immunol. 29:733-44
16. Stefaner I, Praetor A, Hunziker W. 1999. Nonvectorial surface transport, endocytosis via a Di-leucine-based motif, and bidirectional transcytosis of chimera encoding the cytosolic tail of rat FcRn expressed in Madin-Darby canine kidney cells. J. Biol. Chem. 274:8998-9005
17. Simister NE, Mostov KE. 1989. An Fc receptor structurally related to MHC class I antigens. Nature 337:184-87
18. Burmeister WP, Gastinel LN, Simister NE, Blum ML, Bjorkman PJ. 1994. Crystal structure at 2.2 Å resolution of the MHC-related neonatal Fc receptor. Nature 372:336-43
19. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. 1987. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506-12
20. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. 1987. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329: 512-18
21. Zeng Z, Castano AR, Segelke BW, Stura EA, Peterson PA, Wilson IA. 1997. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 277:339-45
22. Joyce S, Woods AS, Yewdell JW, Bennink JR, De Silva AD, Boesteanu A, Balk SP, Cotter RJ, Brutkiewicz RR. 1998. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science 279:1541-44
23. Plaksin D, Polakova K, Mage MG, Margulies DH. 1997. Rigidification of the alpha2 helix of an MHC class I molecule by a valine to proline mutation in position 165 does not prevent peptide-specific antigen presentation. J. Immunol. 159:4408-14
24. Ahouse JJ, Hagerman CL, Mittal P, Gilbert DJ, Copeland NG, Jenkins NA, Simister NE. 1993. Mouse MHC class I-like Fc receptor encoded outside the MHC. J. Immunol. 151:6076-88
25. Story CM, Mikulska JE, Simister NE. 1994. A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus. J. Exp. Med. 180:2377-81
26. Simister NE, Story CM, Chen HL, Hunt JS. 1996. An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta. Eur. J. Immunol. 26:1527-31
27. Leach JL, Sedmak DD, Osborne JM, Rahill B, Lairmore MD, Anderson CL. 1996. Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. J. Immunol. 157:3317-22
28. Kristoffersen EK, Matre R. 1996. Co-localization of the neonatal Fc gamma receptor and IgG in human placental term syncytiotrophoblasts. Eur. J. Immunol. 26:1668-71
29. Kim JK, Tsen MF, Ghetie V, Ward ES. 1994. Localization of the site of the murine IgG1 molecule that is involved in binding to the murine intestinal Fc receptor. Eur. J. Immunol. 24:2429-34
30. Raghavan M, Bonagura VR, Morrison SL, Bjorkman PJ. 1995. Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. Biochemistry 34:14649-57
31. Medesan C, Matesoi D, Radu C, Ghetie V, Ward ES. 1997. Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1. J. Immunol. 158:2211-17
32. Kim J-K, Firan M, Radu CG, Kim C-H, Ghetie V, Ward ES. 1999. Mapping the site on human IgG for binding of the MHC class I related receptor, FcRn. Eur. J. Immunol. 29:2819-25
33. Deisenhofer J. 1981. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9-and 2.8-Å resolution. Biochemistry 20:2361-70
34. Gastinel L, Simister NE, Bjorkman PJ. 1992. Expression and crystalization of a soluble and functional form of an Fc receptor related to class I histocompatibility molecules. Proc. Natl. Acad. Sci. USA 89:638-42
35. Popov S, Hubbard JG, Kim J, Ober B, Ghetie V, Ward ES. 1996. The stoichiometry and affinity of the interaction of murine Fc fragments with the MHC class I-related receptor, FcRn. Mol. Immunol. 33:521-30
36. Guyer RL, Koshland ME, Knopf PM. 1976. Immunoglobulin binding by mouse intestinal epithelial cell receptors. J. Immunol. 117:587-93
37. Vaughn DE, Bjorkman PJ. 1998. Structural basis of pH-dependent antibody binding by the neonatal Fc receptor. Structure 6:63-73
38. Lebron JA, Bennett MJ, Vaughn DE, Chirino AJ, Snow PM, Mintier GA, Feder JN, Bjorkman PJ. 1998. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 93:111-23
39. Medesan C, Cianga P, Mummert M, Stanescu D, Ghetie V, Ward ES. 1998. Comparative studies of rat IgG to further delineate the Fc:FcRn interaction site. Eur. J. Immunol. 28:2092-100
40. Burmeister WP, Huber AH, Bjorkman PJ. 1994. Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature 372:379-83
41. Hobbs SM, Jackson LE, Peppard JV. 1987. Binding of subclasses of rat immunoglobulin G to detergent-isolated Fc receptor from neonatal rat intestine. J. biol. Chem. 262:8041-46
42. Raghavan M, Chen MY, Gastinel LN, Bjorkman PJ. 1994. Investigation of the interaction between the class I MHC-related Fc receptor and its immunoglobulin G ligand. Immunity 1:303-15
43. Dima S, Medesan C, Mota G, Moraru I, Sjoquist J, Ghetie V. 1983. Effect of protein A and its fragment B on the catabolic and Fc receptor sites of IgG. Eur. J. Immunol. 13:605-14
44. Zuckier LS, Chang CJ, Scharff MD, Morrison SL. 1998. Chimeric human-mouse IgG antibodies with shuffled constant region exons demonstrate that multiple domains contribute to in vivo half-life. Cancer Res. 58:3905-8
45. Kim JK, Tsen MF, Ghetie V, Ward ES. 1995. Evidence that the hinge region plays a role in maintaining serum levels of the murine IgG1 molecule. Mol. Immunol. 32:467-75
46. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C. 1991. Sequences of Proteins of Immunological Interest. Washington, DC: U.S. Dep. Health Hum. Serv. 5th ed.
47. Duncan AR, Winter G. 1988. The binding site for C1q on IgG. Nature 332:738-40
48. Frick IM, Wikstrom M, Forsen S, Drakenberg T, Gomi H, Sjobring U, Bjorck L. 1992. Convergent evolution among immunoglobulin G-binding bacterial proteins. Proc. Natl. Acad. Sci. USA 89:8532-36
49. Duncan AR, Woof JM, Partridge LJ, Burton DR, Winter G. 1988. Localization of the binding site for the human high-affinity Fc receptor on IgG. Nature 332:563-64
50. Canfield SM, Morrison SL. 1991. The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region. J. Exp. Med. 173:1483-91
51. Lund J, Pound JD, Jones PT, Duncan AR, Bentley T, Goodall M, Levine BA, Jefferis R, Winter G. 1992. Multiple binding sites on the CH2 domain of IgG for mouse Fc gamma R11. Mol. Immunol. 29:53-59
52. Lund J, Winter G, Jones PT, Pound JD, Tanaka T, Walker MR, Artymiuk PJ, Arata Y, Burton DR, Jefferis R. 1991. Human Fc gamma RI and Fc gamma RII interact with distinct but overlapping sites on human IgG. J. Immunol. 147:2657-62
53. Hogarth PM, Ierino FL, Hulett MD. 1994. Characterization of FcR Ig-binding sites and epitope mapping. Immunomethods 4:17-24
54. Hulett MD, Hogarth PM. 1994. Molecular basis of Fc receptor function. Adv. Immunol. 57:1-127
55. Gavin AL, Barnes N, Dijstelbloem HM, Hogarth PM. 1998. Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity. J. Immunol. 160:20-23
56. Tao MH, Morrison SL. 1989. Studies of aglycosylated chimeric mouse-human IgG: role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J. Immunol. 143:2595-601
57. Tsuchiya N, Endo T, Matsuta K, Yoshinoya S, Aikawa T, Kosuge E, Takeuchi F, Miyamoto T, Kobata A. 1989. Effects of galactose depletion from oligosaccharide chains on immunological activities of human IgG. J. Rheumatol. 16:285-90
58. Walker MR, Lund J, Thompson KM, Jefferis R. 1989. Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing Fc gamma RI and/or Fc gamma RII receptors. Biochem. J. 259:347-53
59. Wright A, Morrison SL. 1994. Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1. J. Exp. Med. 180:1087-96
60. Lund J, Takahashi N, Pound JD, Goodall M, Jefferis R. 1996. Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains. J. Immunol. 157:4963-69
61. Maxwell KF, Powell MS, Hulett MD, Barton PA, McKenzie IF, Garrett TP, Hogarth PM. 1999. Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa. Nat. Struct. Biol. 6:437-42
62. Sondermann P, Huber R, Jacob U. 1999. Crystal structure of the soluble form of the human Fc gamma-receptor IIb: a new member of the immunoglobulin super-family at 1.7 Å resolution. EMBO J. 18:1095-103
63. Wawrzynczak EJ, Denham S, Parnell GD, Cumber AJ, Jones PT, Winter G. 1992. Recombinant mouse monoclonal antibodies with single amino acid substitutions affecting C1q and high affinity Fc receptor binding have identical serum half-lives in the BALB/c mouse. Mol. Immunol. 29:221-27
64. Vaughn DE, Milburn CM, Penny DM, Martin WL, Johnson JL, Bjorkman PJ. 1997. Identification of critical IgG binding epitopes on the neonatal Fc receptor. J. Mol. Biol. 274:597-607
65. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, Wilson IA. 1996. An alphabeta T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science 274:209-19
66. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134-41
67. Raghavan M, Wang Y, Bjorkman PJ. 1995. Effects of receptor dimerization on the interaction between the class I major histocompatibility complex-related Fc receptor and IgG. Proc. Natl. Acad. Sci. USA 92:11200-4
68. Vaughn DE, Bjorkman PJ. 1997. High-affinity binding of the neonatal Fc receptor to its IgG ligand requires receptor immobilization. Biochemistry 36:9374-80
69. Weng Z, Gulukota K, Vaughn DE, Bjorkman PJ, DeLisi C. 1998. Computational determination of the structure of rat Fc bound to the neonatal Fc receptor. J. Mol. Biol. 282:217-25
70. Huber AH, Kelley RF, Gastinel LN, Bjorkman PJ. 1993. Crystallization and stoichiometry of binding of a complex between a rat intestinal Fc receptor and Fc. J. Mol. Biol. 230:1077-83
71. Kim JK, Tsen MF, Ghetie V, Ward ES. 1994. Catabolism of the murine IgG1 molecule: evidence that both CH2-CH3 domain interfaces are required for persistence of IgG1 in the circulation of mice. Scand. J. Immunol. 40:457-65
72. Fersht AR. 1975. Demonstration of two active sites on a monomeric aminoacyl-tRNA synthetase: possible roles of negative cooperativity and half-of-the-sites reactivity in oligomeric enzymes. Biochemistry 14:5-12
73. Bosshard HR, Koch LE, Hartley BS. 1975. Aminoacyl-tRNA synthetases from Bacillus stearothermophilus: asymmetry of substrate binding to tyrosyl-tRNA synthetase. Eur. J. Biochem. 53:493-98
74. Nezlin R. 1990. Internal movements in immunoglobulin molecules. Adv. Immunol. 48:1-40
75. Burton DR. 1990. Antibody: the flexible adaptor molecule. Trends Biochem. Sci. 15:64-69
76. Zheng Y, Shopes B, Holowka D, Baird B. 1992. Dynamic conformations compared for IgE and IgG1 in solution and bound to receptors. Biochemistry 31:7446-56
77. Keown MB, Ghirlando R, Young RJ, Beavil AJ, Owens RJ, Perkins SJ, Sutton BJ, Gould HJ. 1995. Hydrodynamic studies of a complex between the Fc fragment of human IgE and a soluble fragment of the Fc epsilon RI alpha chain. Proc. Natl. Acad. Sci. USA 92:1841-45
78. Robertson MW. 1993. Phage and Escherichia coli expression of the human high affinity immunoglobulin E receptor alpha-subunit ectodomain: domain localization of the IgE-binding site. J. Biol. Chem. 268:12736-43
79. Sanchez LM, Penny DM, Bjorkman PJ. 1999. Stoichiometry of the interaction between the MHC-related Fc receptor and its Fc ligand. Biochemistry 38:9471-76.
80. Schuck P, Radu CG, Ward ES. 1999. Sedimentation equilibrium analysis of recombinant mouse FcRn with murine IgG1. Mol. Immunol. 36:1117-25
81. Ghetie V, Popov S, Borvak J, Radu C, Matesoi D, Medesan C, Ober RJ, Ward ES. 1997. Increasing the serum persistence of an IgG fragment by random mutagenesis. Nat. Biotechnol. 15:637-40
82. Raghavan M, Bjorkman PJ. 1996. Fc receptors and their interactions with immunoglobulins. Annu. Rev. Cell Dev. Biol. 12:181-220
83. Bjorkman PJ. 1998. Antibodies: Molecular, Cellular and Clinical Aspects. Cancer Res. Inst. (Abstr.), April 1998
84. Rodewald R, Kraehenbuhl JP. 1984. Receptor-mediated transport of IgG. J. Cell Biol. 99:159s-64s
85. Israel EJ, Patel VK, Taylor SF, Marshak-Rothstein A, Simister NE. 1995. Requirement for a beta 2-microglobulin-associated Fc receptor for acquisition of maternal IgG by fetal and neonatal mice. J. Immunol. 154:6246-51
86. Benlounes N, Chedid R, Thuillier F, Desjeux JF, Rousselet F, Heyman M. 1995. Intestinal transport and processing of immunoglobulin G in the neonatal and adult rat. Biol. Neonate 67:254-63
87. Kristoffersen EK, Ulvestad E, Vedeler CA, Matre R. 1990. Fc gamma receptor heterogeneity in the human placenta. Scand. J. Immunol. 32:561-64
88. Simister NE, Story CM. 1997. Human placental Fc receptors and the transmission of antibodies from mother to fetus. J. Reprod. Immunol. 37:1-23
89. Leach L, Eaton BM, Firth JA, Contractor SF. 1991. Immunocytochemical and labelled tracer approaches to uptake and intracellular routing of immunoglobulin-G (IgG) in the human placenta. Histochem. J. 23:444-49
90. Stefaner I, Stefanescu A, Hunziker W, Fuchs R. 1997. Expression of placental alkaline phosphatase does not correlate with IgG binding, internalization and transcytosis. Biochem. J. 327:585-92
91. Kameda T, Koyama M, Matsuzaki N, Taniguchi T, Saji F, Tanizawa O. 1991. Localization of three subtypes of Fc gamma receptors in human placenta by immunohistochemical analysis. Placenta 12:15-26
92. Sedmak DD, Davis DH, Singh U, van de Winkel JG, Anderson CL. 1991. Expression of IgG Fc receptor antigens in placenta and on endothelial cells in humans. An immunohistochemical study. Am. J. Pathol. 138:175-81
93. Wang AC, Faulk WP, Stuckey MA, Fudenberg HH. 1970. Chemical differences of adult, fetal and hypogammaglobulinemic IgG immunoglobulins. Immunochemistry 7:703-8
94. Hay FC, Hull MG, Torrigiani G. 1971. The transfer of human IgG subclasses from mother to foetus. Clin. Exp. Immunol. 9:355-58
95. Malek A, Sager R, Schneider H. 1994. Maternal-fetal transport of immunoglobulin G and its subclasses during the third trimester of human pregnancy. Am. J. Reprod. Immunol. 32:8-14
96. Sidiripoulos D, Hermann U, Morell A, Muratt G, Barundun S. 1986. Transplacental passage of intravenous immunoglobulin in the last trimester of pregnancy. J. Pedriatr. 109:505-8
97. Smith CIE, Hammarstrom L. 1985. Intravenous immunoglobulin in pregnancy. Obstet. Gynecol. 66:39S-40S
98. Malek A, Sager R, Sakher A, Schneider H. 1995. Transport of immunoglobulin G and its subclasses across the in vitro perfused human placenta. Am. J. Obstet. Gynecol. 173:760-67
99. Sooranna SR Contractor SF. 1991. Vectorial transcytosis of immunoglobulin G by human term trophoblast cells in culture. Exp. Cell Res. 192:41-45
100. Brambell FWR, Hemmings WA, Morris IG. 1964. A theoretical model of gammaglobulin catabolism. Nature 203: 1352-55
101. Brambell FWR. 1970. The Transmission of Passive Immunity from Mother to Young. Amsterdam: North Holland
102. Kim JK, Tsen MF, Ghetie V, Ward ES. 1994. Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site-directed mutagenesis. Eur. J. Immunol. 24:542-48
103. Spriggs MK, Koller BH, Sato T, Morrissey PJ, Fanslow WC, Smithies O, Voice RF, Widmer MB, Maliszewski CR. 1992. Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc. Natl. Acad. Sci. USA 89:6070-74
104. Liu Z, Roopenian DC, Zhou X, Christianson GJ, Diaz LA, Sedmak DD, Anderson CL. 1997. Beta2-microglobulin-deficient mice are resistant to bullous pemphigoid. J. Exp. Med. 186:777-83
105. Mozes E, Kohn LD, Hakim F, Singer DS. 1993. Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus. Science 261:91-93
106. Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ. 1999. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189:1639-48
107. Simister NE, Mostov KE. 1989. Cloning and expression of the neonatal rat intestinal Fc receptor, a major histocompatibility complex class I antigen homolog. Cold Spring Harb. Symp. Quant. Biol. 54(1):571-80
108. Junghans RP. 1997. Finally! The Brambell receptor (FcRB). Mediator of transmission of immunity and protection from catabolism for IgG. Immunol. Res. 16:29-57
109. Mariani G, Strober W. 1990. Immunoglobulin Metabolism, Fc Receptors, and the Action of Antibodies, ed. H Metzger, pp. 94-177. Washington, DC: Am. Soc. Microbiol.
110. Borvak J, Richardson J, Medesan C, Antohe F, Radu C, Simionescu M, Ghetie V, Ward ES. 1998. Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice. Int. Immunol. 10:1289-98
111. Gitlin D, Kumate J, Urrusti J, Morales C. 1964. The selectivity of the human placenta in the transfer of plasma proteins from mother to fetus. J. Clin. Invest. 43:1938-51
112. Contractor SF, Eaton BM, Stannard PJ. 1983. Uptake and fate of exogenous immunoglobulin G in the perfused human placenta. J. Reprod. Immunol. 5:265-73
113. Israel EJ, Taylor S, Wu Z, Mizoguchi E, Blumberg RS, Bhan A, Simister NE. 1997. Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells. Immunology 92:69-74
114. Dickinson BL, Badizadegan K, Wu Z, Ahouse X, Simister NE, Blumberg RS, Lencer WI. 1999. Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. J. Clin. Invest. 104:903-11
115. Besser TE, McGuire TC, Gay CC, Pritchett LC. 1988. Transfer of functional immunoglobulin G (IgG) antibody into the gastrointestinal tract accounts for IgG clearance in calves. J. Virol. 62:2234-37
116. Blumberg RS, Koss T, Story CM, Barisani D, Polischuk J, Lipin A, Pablo L, Green R, Simister NE. 1995. A major histocompatibility complex class I-related Fc receptor for IgG on rat hepatocytes. J. Clin. Invest. 95:2397-402
117. Cianga P, Medesan C, Richardson J, Ghetie V, Ward ES. 1999. Identification and function of neonatal Fc receptor in mammary gland of lactating mice. Eur. J. Immunol. 29:2515-23
118. Mehta PD, Isaacs CE, Coyle PK. 1991. Immunoglobulin G subclasses in human colostrum and milk. In Immunology of Milk and the Neonate, ed. J Mestecky, C Blair, PL Ogra, pp. 223-26. New York and London: Plenum
119. Hunziker W, Fumey C. 1994. A di-leucine motif mediates endocytosis and basolateral sorting of macrophage IgGFc receptors in MDCK cells. EMBO J. 13:2963-67
120. Letourneur F, Klausner RD. 1992. A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains. Cell 69:1143-57
121. Simmen T, Nobile M, Bonifacino JS, Hunziker W. 1999. Basolateral sorting of furin in MDCK cells requires a phenylalanine-isoleucine motif together with an acidic amino acid cluster. Mol. Cell Biol. 19:3136-44
122. Mostov KE, Deitcher DL. 1986. Polymeric immunoglobulin receptor expressed in MDCK cells transcytoses IgA. Cell 46:613-21
123. Hunziker W, Mellman I. 1989. Expression of macrophage-lymphocyte Fc receptors in Madin-Darby canine kidney cells: polarity and transcytosis differ for isoforms with or without coated pit localization domains. J. Cell Biol. 109:3291-302
124. Sell S, Fahey JL. 1964. Relationship between gamma-globulin metabolism and low serum gamma-globulin in germ-free mice. J. Immunol. 93:81-87
125. Kandil E, Noguchi M, Ishibashi T, Kasahara M. 1995. Structural and phylogenetic analysis of the MHC class I-like Fc receptor gene. J. Immunol. 154:5907-18
126. Hansborough JR, Miller LN, Field TO, Gadd NA. 1988. High dose intravenous immunoglobulin therapy in burn patients, pharmacokinetics and effects on microbial opsonization and phagocytosis. Pediatr. Infect. Dis. 7:S49-S46
127. Wochner RD, Drews G, Strober W, Waldmann TA. 1966. Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: a hereditary error of immunoglobulin catabolism. J. Clin. Invest. 45:321-29
128. Waldmann TA, Miller EJ, Terry WD. 1968. Hypercatabolism of IgG and albumin: a new familial disorder. Clin. Res. 16:45
129. Yu Z, Lennon VA. 1999. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N. Engl. J. Med. 340:227-28
130. Masson PL. 1993. Elimination of infectious antigens and increase of IgG catabolism as possible modes of action of IVIg. J. Autoimmun. 6:683-89
131. Geha RS, Rosen FS. 1996. Intravenous immune globulin therapy. In Therapeutic Immunology, ed. KF Austen, SJ Burakoff, FS Rosen, TB Strom, pp. 280-96. Cambridge, MA: Blackwell Science
132. Martin MG, Wu SV, Walsh JH. 1993. Hormonal control of intestinal Fc receptor gene expression and immunoglobulin transport in suckling rats. J. Clin. Invest. 91:2844-49
133. Levy AL, Waldmann TA. 1970. The effect of hydrocortisone on immunoglobulin metabolism. J. Clin. Invest. 49: 1679-84
134. Riechmann L, Holliger P. 1997. Antibodies live long and prosper. Nat. Biotechnol. 15:617
135. Baselga JD, Tripathy D, Mendelsohn J, Baughman S, Benz CC, Dantis L, Sklarin NT, Seidman AD, Hudis CA, Moore J, Rosen PP, Twaddell T, Henderson IC, Norton L. 1996. Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal Ab in patients with HER2/neu-overexpressing metastatic breast cancer. J. Clin. Oncol. 14:737-44
136. Berinstein NL, Grillo-Lopez AJ, White CA, Bence-Bruckler I, Maloney D, Czuczman M, Green D, Rosenberg J, McLaughlin P, Shen D. 1998. Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma. Ann. Oncol. 9:995-1001
137. Uhr JW, Baumann J. 1961. Antibody formation: I. The suppression of antibody formation by passively administered antibody. J. Exp. Med. 113:395-97
138. Celis E, Zurawski VRJ, Chang TW. 1984. Regulation of T-cell function by antibodies: enhancement of the response of human T-cell clones to hepatitis B surface antigen by antigen-specific monoclonal antibodies. Proc. Natl. Acad. Sci. USA 81:6846-50
139. Schalke BC, Klinkert WE, Wekerle H, Dwyer DS. 1985. Enhanced activation of a T cell line specific for acetylcholine receptor (AChR) by using anti-AChR monoclonal antibodies plus receptors. J. Immunol. 134:3643-48
140. Jemmerson R, Johnson JG, Burrell E, Taylor PS, Jenkins MK. 1991. A monoclonal antibody specific for a cytochrome c T cell stimulatory peptide inhibits T cell responses and affects the way the peptide associates with antigen-presenting cells. Eur. J. Immunol. 21:143-51
141. Watts C, Lanzavecchia A. 1993. Suppressive effect of antibody on processing of T cell epitopes. J. Exp. Med. 178:1459-63
142. Siegrist CA, Barrios C, Martinez X, Brandt C, Berney M, Cordova M, Kovarik J, Lambert PH. 1998. Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice. Eur. J. Immunol. 28:4138-48
143. Simionescu M, Simionescu N. 1991. Endothelial transport of macromolecules: transcytosis and endocytosis. Cell Biol. Rev. 25:1-78
144. Martin WL, Bjorkman PJ. 1999. Characterization of the 2:1 complex between the class I MHC related Fc receptor and its Fc ligand in solution. Biochemistry 38:12639-47